Posted in | News

New Polyethylene Pilot Plant to be Built at Chevron Phillips Chemical’s Bartlesville Research Center

Chevron Phillips Chemical Company LP (Chevron Phillips Chemical) is pleased to announce plans to build a state-of-the-art polyethylene pilot plant at its research and technology facility in Bartlesville, Oklahoma.

The new pilot plant will incorporate Chevron Phillips Chemical’s proprietary MarTECH™ loop slurry process for polyethylene production and MarTECH™ ADL (advanced dual loop) technology, a proprietary dual loop process enabling production of bimodal polyethylene resins for advanced applications.

The premier testing site will provide leading-edge polyethylene research, including new catalyst and polymer development, as well as polymer performance enhancements. Construction is scheduled to begin in 2015.

“As a global producer of polyethylene, we strive to support our customers with the latest technological advances and process improvements through the efforts of our research and development personnel,” said Don Lycette, vice president of research and technology for Chevron Phillips Chemical. “Chevron Phillips Chemical continues to build on a long history of scientific discoveries, particularly at our facility in Bartlesville, which was originally built in 1950 by Phillips Petroleum Company.”

All MarTECH™ technology delivers reliable, high-reactor throughput while minimizing capital expense, operating costs and environmental impact, and it is utilized by numerous commercial reactor facilities worldwide.

Completion of the new pilot plant is expected in 2017.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.